Sofie Pavitt Face Reset Benzoyl Peroxide Acne Treatment Mask Paste
NDC Package 52261-7301-2
Package Information
Sofie Pavitt Face Reset Benzoyl Peroxide Acne Treatment Mask (benzoyl peroxide) pastes is a medication used to treat mild to moderate acne. This formulation utilizes a paste delivery system. Marketed by Cosco International, Inc., this product is identified by NDC 52261-7301 and is authorized under FDA application M006.
Identification & Billing
- RxCUI: 308696 - benzoyl peroxide 5 % Medicated Liquid Soap
- RxCUI: 308696 - benzoyl peroxide 50 MG/ML Medicated Liquid Soap
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 52261 - Cosco International, Inc.
- 52261-7301 - Sofie Pavitt Face Reset Benzoyl Peroxide Acne Treatment Mask
- 52261-7301-2 - 1 TUBE in 1 CARTON / .0313 kg in 1 TUBE
- 52261-7301 - Sofie Pavitt Face Reset Benzoyl Peroxide Acne Treatment Mask
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (52261-7301). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 52261-7301-2 identifies a specific commercial package of 1 tube in 1 carton / .0313 kg in 1 tube of Sofie Pavitt Face Reset Benzoyl Peroxide Acne Treatment Mask, a human over the counter drug labeled by Cosco International, Inc.. This paste is formulated for topical use and contains benzoyl peroxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cosco International, Inc. on November 11, 2024. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat mild to moderate acne. It may be used in combination with other acne treatments. When applied to the skin, benzoyl peroxide works by reducing the amount of acne-causing bacteria and by causing the skin to dry and peel. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.
How is this Cosco International, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 52261730102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.